Back to mobile site

FDA approves Pfizer's (PFE) migraine nasal spray

March 10, 2023 11:44 AM EST Send to a Friend
Pfizer (NYSE: PFE) shares edged higher despite the overall dip in equities in the early part of Friday's session after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login